mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.002 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |